These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38102663)

  • 21. Roles of Ferroptosis in Cardiovascular Diseases.
    Guo Y; Zhang W; Zhou X; Zhao S; Wang J; Guo Y; Liao Y; Lu H; Liu J; Cai Y; Wu J; Shen M
    Front Cardiovasc Med; 2022; 9():911564. PubMed ID: 35677693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferroptosis: a new strategy for cardiovascular disease.
    Wang Y; Wu J
    Front Cardiovasc Med; 2023; 10():1241282. PubMed ID: 37731525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ferroptosis in effects of anesthetics on multiple organ diseases: A literature review.
    Abudurousuli G; Xu S; Che J; Ding X; Gui B; Zhu L
    Heliyon; 2023 Oct; 9(10):e20405. PubMed ID: 37780755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging Potential Therapeutic Targets of Ferroptosis in Skeletal Diseases.
    Liu X; Wang T; Wang W; Liang X; Mu Y; Xu Y; Bai J; Geng D
    Oxid Med Cell Longev; 2022; 2022():3112388. PubMed ID: 35941905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease.
    Xie LH; Fefelova N; Pamarthi SH; Gwathmey JK
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy.
    Zhai Z; Zou P; Liu F; Xia Z; Li J
    Front Cell Dev Biol; 2021; 9():649045. PubMed ID: 33869204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis and its role in cardiomyopathy.
    Li D; Pi W; Sun Z; Liu X; Jiang J
    Biomed Pharmacother; 2022 Sep; 153():113279. PubMed ID: 35738177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferroptosis and its emerging roles in cardiovascular diseases.
    Li N; Jiang W; Wang W; Xiong R; Wu X; Geng Q
    Pharmacol Res; 2021 Apr; 166():105466. PubMed ID: 33548489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.
    Ravingerová T; Kindernay L; Barteková M; Ferko M; Adameová A; Zohdi V; Bernátová I; Ferenczyová K; Lazou A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of microRNAs in ferroptosis.
    Guo L; Zhang Q; Liu Y
    Front Mol Biosci; 2022; 9():1003045. PubMed ID: 36310600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular mechanisms of ferroptosis and its role in cardiovascular disease.
    Zhang Y; Xin L; Xiang M; Shang C; Wang Y; Wang Y; Cui X; Lu Y
    Biomed Pharmacother; 2022 Jan; 145():112423. PubMed ID: 34800783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferroptosis in cardiovascular disease.
    Liu G; Xie X; Liao W; Chen S; Zhong R; Qin J; He P; Xie J
    Biomed Pharmacother; 2024 Jan; 170():116057. PubMed ID: 38159373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
    Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
    Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferroptosis: A Potential Target in Cardiovascular Disease.
    Leng Y; Luo X; Yu J; Jia H; Yu B
    Front Cell Dev Biol; 2021; 9():813668. PubMed ID: 35127725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLC7A11-associated ferroptosis in acute injury diseases: mechanisms and strategies.
    Li P; Yu J; Huang F; Zhu YY; Chen DD; Zhang ZX; Xie ZC; Liu ZY; Hou Q; Xie N; Peng TH; Chen X; Li L; Xie W
    Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4386-4398. PubMed ID: 37259719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posttranslational Modifications in Ferroptosis.
    Wei X; Yi X; Zhu XH; Jiang DS
    Oxid Med Cell Longev; 2020; 2020():8832043. PubMed ID: 33294126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Flavonoids and Ferroptosis: Potential Therapeutic Opportunities for Human Diseases.
    Zhou Z; Li J; Zhang X
    J Agric Food Chem; 2023 Apr; ():. PubMed ID: 37027486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis: mechanisms and links with diseases.
    Yan HF; Zou T; Tuo QZ; Xu S; Li H; Belaidi AA; Lei P
    Signal Transduct Target Ther; 2021 Feb; 6(1):49. PubMed ID: 33536413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferroptosis in Liver Diseases: An Overview.
    Capelletti MM; Manceau H; Puy H; Peoc'h K
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Mechanisms and Disease Relevance of Ferroptosis.
    Stockwell BR; Jiang X; Gu W
    Trends Cell Biol; 2020 Jun; 30(6):478-490. PubMed ID: 32413317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.